Copper slump chisels £655m off miner Antofagasta (ANTO)
Shares in Jackpotjoy (JPJ) fell 64p, to 950p as it announced first-half earnings had slipped by 4% to £56.9million. Though investors were unimpressed, analysts at broker Numis said the figures were ‘reassuring’ and retained their ‘buy’ rating on the stock.
Realm Therapeutics (RLM) – a biopharmaceutical company which focuses on finding cures for diseases involving the body’s immune system – sank 51.3%, or 20.5p, to 19.5p. Investors backed away from the business as it announced that its latest drug, which it hoped would treat eczema, was ineffective in clinical trials.
Shareholders in Salvarx Group (SALV) received a positive surprise. Shares shot up 43.5%, or 19.4p, to 64p as the company announced it was selling its subsidiary to Canada-listed Portage Biotech
– Debenhams (DEB) shares lifted by rumours Mike Ashley might merge it with House of Fraser. Ashley owns just under 30% of Debenhams’s issued share capital, close to the threshold at which he must launch an official takeover bid.
Gucci, Prada… and : The brands Mike Ashley says will save House of Fraser
House of Fraser suppliers could be left out of pocket as Mike Ashley’s draws a line under payments
Royal Mail (RMG) is fined £50million for ‘serious breach of competition law’ after ‘discriminating against’ its only major competitor Whistl with price hike plan
